20.39
+0.47(+2.36%)
Currency In USD
| Previous Close | 19.92 |
| Open | 20 |
| Day High | 20.39 |
| Day Low | 19.8 |
| 52-Week High | 42.12 |
| 52-Week Low | 3.66 |
| Volume | 5,915 |
| Average Volume | 17,000 |
| Market Cap | 22.5M |
| PE | -0.77 |
| EPS | -26.64 |
| Moving Average 50 Days | 19.92 |
| Moving Average 200 Days | 13.9 |
| Change | 0.47 |
If you invested $1000 in Apollomics, Inc. (APLM) since IPO date, it would be worth $20.6 as of March 12, 2026 at a share price of $20.39. Whereas If you bought $1000 worth of Apollomics, Inc. (APLM) shares 3 years ago, it would be worth $19.36 as of March 12, 2026 at a share price of $20.39.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apollomics Announces Settlement of Cayman Litigation
GlobeNewswire Inc.
Nov 19, 2025 10:38 PM GMT
FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”) (Nasdaq: APLM) announced today entering into a settlement agreement (the “Settlement Agreement” or the “Agreement”) with TWVC Goldlink Partners I
Apollomics Announces Changes to its Board of Directors and Composition of Committees
GlobeNewswire Inc.
Nov 18, 2025 4:00 AM GMT
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the C
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
GlobeNewswire Inc.
Oct 15, 2025 6:36 PM GMT
Nasdaq Hearing Cancellation and Continued ListingFOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California based late-stage clinical biopharmaceutical company developing mult